SAN FRANCISCO, Nov. 17, 2010 /PRNewswire/ -- Sutro Biopharma today announced that the company has secured $36.5 million in Series C financing.

SAN DIEGO, Nov. 11, 2010 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, announced today that it has closed its Series D preferred financing in the amount of $11.5 million.

SAN DIEGO, Oct. 26 /PRNewswire/ -- aTyr Pharma, the physiocrine therapeutics company, today announced a $23 million Series C equity financing led by Domain Associates.

REDWOOD CITY, Calif., Oct. 6 /PRNewswire/ -- Pathwork Diagnostics, Inc, a privately held molecular diagnostics company focused on oncology, today announced the closing of its $30 million Series C financing.

BOSTON, and MELBOURNE, Australia, June 7 /PRNewswire/ -- Opal Therapeutics Inc. (Opal) and Massachusetts General Hospital (MGH) have entered into a joint development collaboration agreement to develop a novel immunotherapy to treat HIV.